Taiyen Biotech Reports Third-Quarter Net Profit of NT$59.6 Million
Taiyen Biotech’s third-quarter revenue was NT$825.049 million, compared with NT$814.822 million a year earlier. Pretax profit was NT$79.67 million versus NT$100.121 million.
Taiyen Biotech Co. Ltd. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars.
2026 2025 Revenue NT$825,049,000 NT$814,822,000 Pretax Profit NT$79,670,000 NT$100,121,000 Net Profit…